Keyphrases
Area under the Receiver Operating Characteristic Curve
7%
Artificial Intelligence
7%
Biologic Therapy
7%
Biological Therapy
7%
Chromoendoscopy
7%
Colonoscopy
10%
Colonoscopy Quality
11%
Confidence Interval
9%
Confocal Laser Endomicroscopy
9%
Crohn's Colitis
7%
Crohn's Disease
37%
Direct Observation of Procedural Skills
8%
Disease Groups
6%
Disease Surveillance
9%
Disease-associated
8%
Dysplasia
17%
Endoscopic Healing
8%
Endoscopic Remission
7%
Endoscopic Technique
7%
Endoscopy
23%
Histological Healing
11%
Histological Index
12%
Histological Remission
12%
Histological Score
7%
Histology
11%
Histopathological Features
6%
I-scan
15%
Inflammation
14%
Inflammatory Bowel Disease
100%
Interobserver Agreement
9%
Lamina Propria
6%
Mayo Endoscopic Subscore
9%
Meta-analysis
8%
Mucosa
9%
Mucosal Healing
29%
Neoplasia
12%
Optical Diagnosis
9%
Optical Enhancement
13%
Oral Targeted Therapy
8%
Paddington
11%
Probe-based Confocal Laser Endomicroscopy (pCLE)
6%
Sessile Serrated Adenoma
8%
Surveillance Colonoscopy
13%
Systematic Meta-analysis
8%
T Helper 17 (Th17)
6%
Targeted Biopsy
9%
Ulcerative Colitis
57%
Ulcerative Colitis Patient
7%
Virtual Chromoendoscopy
29%
White Light
8%
Medicine and Dentistry
Adenoma
10%
Adverse Event
8%
Biological Therapy
13%
Biopsy Technique
16%
Chromoendoscopy
35%
Chronicity
6%
Colitis
9%
Colon
5%
Colonoscopy
35%
Colorectal Carcinoma
6%
Colorectal Polyp
14%
Confocal Laser Scanning Microscopy
15%
COVID-19
7%
Crohn's Disease
23%
Diagnosis
13%
Diagnostic Accuracy
6%
Disease Surveillance
6%
Diseases
12%
Dysplasia
22%
Echography
5%
Endomicroscopy
5%
Endoscopy
29%
Eosinophilic Esophagitis
5%
Faecal Calprotectin
8%
Immunity
5%
Immunosuppressive Drug
6%
Inflammatory Bowel Disease
97%
Intubation
6%
Lamina Propria
5%
Meta-Analysis
8%
Mucosa
7%
Neoplasm
13%
Patient with Crohn's Disease
5%
Patient with Inflammatory Bowel Disease
15%
Patient with Ulcerative Colitis
5%
Polyp
13%
Prevalence
12%
Prospective Study
5%
Rectum Adenoma
5%
SCAN
7%
Stricture
6%
Systematic Review
9%
T-Helper Cell
8%
Targeted Therapy
9%
Tumor Necrosis Factor
6%
Ulcerative Colitis
56%
